Skip to main navigation Skip to search Skip to main content

An improved high‐pressure liquid chromatographic assay for secobarbital in serum

  • H. L. Levine
  • , M. E. Cohen
  • , P. K. Duffner
  • , K. A. Kustas
  • , D. D. Shen
  • SUNY Buffalo
  • Duquesne University

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

A high‐pressure liquid chromatographic method for the analysis of secobarbital in serum was developed. Secobarbital was extracted from buffered serum (pH 5.5) with a solvent mix of hexane‐ether‐n‐propanol. 5‐(4‐Methylphenyl)‐5‐phenylhydantoin was added as an internal standard. Separation of secobarbital and internal standard from serum constituents and other drugs was achieved on a 5‐μm C‐18 reversed‐phase column using an acetonitrile‐phosphate buffer (pH 4.4) mobile phase. The eluent was monitored at 195 mm. The sensitivity limit of the assay was ∼0.02 μg/ml with 0.5 ml of serum sample. The application of this method to pharmacokinetic studies in pediatric patients was demonstrated.

Original languageEnglish
Pages (from-to)1281-1283
Number of pages3
JournalJournal of Pharmaceutical Sciences
Volume71
Issue number11
DOIs
StatePublished - Nov 1982

Keywords

  • Anticonvulsants—secobarbital, high‐pressure liquid chromatographic assay in human serum, pharmacokinetics
  • High‐pressure liquid chromatography—secobarbital, anticonvulsant, pharmacokinetics, human serum
  • Keyphrases
  • Pharmacokinetics—secobarbital, high‐pressure liquid chromatographic assay in human serum, anticonvulsant
  • Secobarbital—high‐pressure liquid chromatographic assay in human serum, anticonvulsants, pharmacokinetics

Fingerprint

Dive into the research topics of 'An improved high‐pressure liquid chromatographic assay for secobarbital in serum'. Together they form a unique fingerprint.

Cite this